Laparoscopic adenomyomectomy combined with levonorgestrel‐releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness
Authors:
- 10 November 2020
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (2) , 613-620
Abstract
Aim To evaluate the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative replacement of levonorgestrel‐releasing intrauterine system (LNG‐IUS) in the treatment of symptomatic adenomyosis. Methods This is a case‐series study in a university medical center. A total of 52 patients with symptomatic adenomyosis were treated by laparoscopic adenomyomectomy combined with intraoperative replacement of LNG‐IUS from January 2015 to July 2018. Visual analog scale, menstrual flow and uterine volume were compared before and after the surgery (3, 12 and 24 months). Meanwhile, LNG‐IUS‐induced adverse reactions (e.g. irregular vaginal bleeding, amenorrhea, expulsion, and perforation) were also recorded. Results All operations were successfully completed via laparoscopy without conversion to laparotomy. No severe complications were noted during the surgical procedure or follow‐up period. The mean postoperative visual analog scale and menstrual flow scores and the volume of the uterus were significantly decreased (all P < 0.001) at 3, 12, and 24 months postoperatively, compared with preoperative scores. The clinical effective rates among the patients with dysmenorrhea were 98%, 96% and 96% at 3, 12 and 24 months after the operation, respectively. And the clinical effectiveness rate of menorrhagia was 97.6%, 95.2% and 95.2% at 3, 12 and 24 months after treatment, respectively. Among all related adverse reactions, amenorrhea was the most common (n = 12, 23.1%). There was one case of LNG‐IUS perforation (1.9%) and two cases of expulsion (3.8%). Conclusion Laparoscopic adenomyomectomy combined with intraoperative replacement of LNG‐IUS is a novel and effective conservative surgical procedure for symptomatic adenomyosis treatment.Keywords
Funding Information
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81701402)
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
This publication has 28 references indexed in Scilit:
- Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of AdenomyosisMedical Principles and Practice, 2013
- Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?Archives of Gynecology and Obstetrics, 2013
- How can we measure endometriosis-associated pelvic pain?Journal of Endometriosis and Pelvic Pain Disorders, 2012
- Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomesHuman Reproduction Update, 2012
- Management of Adenomyosis in Subfertile Women and Pregnancy OutcomeOman Medical Journal, 2011
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosisContraception, 2009
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosisAmerican Journal of Obstetrics and Gynecology, 2008
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imagingContraception, 2007
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-upHuman Reproduction, 2005
- Validating a pencil-and-paper measure of perimenopausal menstrual blood lossWomen's Health Issues, 2004